Market revenue in 2023 | USD 2.8 million |
Market revenue in 2030 | USD 4.0 million |
Growth rate | 5.2% (CAGR from 2023 to 2030) |
Largest segment | Cardiopulmonary perfusion system |
Fastest growing segment | Cardiopulmonary Perfusion System |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Cardiopulmonary Perfusion System, Cell Perfusion System, Ex-Vivo Organ Perfusion System |
Key market players worldwide | Getinge AB ADR, Medtronic PLC, LivaNova PLC, Terumo Corp, Nipro Corp, Fresenius Medical Care AG, Repligen Corp, Spectrum Brands Holdings Inc, Merck KGaA, Xvivo Perfusion AB |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to perfusion systems market will help companies and investors design strategic landscapes.
Cardiopulmonary perfusion system was the largest segment with a revenue share of 46.43% in 2023. Horizon Databook has segmented the Kuwait perfusion systems market based on cardiopulmonary perfusion system, cell perfusion system, ex-vivo organ perfusion system covering the revenue growth of each sub-segment from 2018 to 2030.
Kuwait has been investing significantly in its healthcare infrastructure to enhance medical facilities and services nationwide. This includes the construction of new hospitals and clinics alongside the modernization of existing facilities, enhancing the overall healthcare landscape.
These developments can cater to the growing healthcare demands of Kuwait’s population and pave the way for integrating advanced medical technologies, such as perfusion systems. By upgrading healthcare facilities with state-of-the-art equipment, Kuwait aims to bolster its healthcare capabilities, improve treatment outcomes, and meet international standards in healthcare delivery.
As part of Kuwait’s USD 104 billion National Development Plan, substantial enhancements to the country’s healthcare infrastructure and facilities are underway, with ongoing planned projects. Obesity, diabetes, and cancer are increasingly prevalent among the Kuwaiti population, highlighting a growing demand for specialized healthcare services of high quality in the years ahead.
Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait perfusion systems market , including forecasts for subscribers. This country databook contains high-level insights into Kuwait perfusion systems market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account